Connect with us

Hi, what are you looking for?

Thursday, Jul 3, 2025

Mugglehead Investment Magazine

Alternative investment news based in Vancouver, B.C.

Mugglehead Investment Magazine

All posts tagged "FDA"

Johnson & Johnson subsidiary sued for USD$147M for breaching antitrust rules in California

Johnson & Johnson subsidiary sued for USD$147M for breaching antitrust rules in California

Medical and Pharmaceutical

Johnson & Johnson subsidiary sued for USD$147M for breaching antitrust rules in California

The lawsuit exposes and brings closer scrutiny to “potentially anticompetitive” tactics by original equipment manufacturers

Joseph MortonMay 21, 2025

Onc.AI's lung cancer analysis tool gets Breakthrough Device Designation from FDA

Onc.AI's lung cancer analysis tool gets Breakthrough Device Designation from FDA

AI and Autonomy

Onc.AI’s lung cancer analysis tool gets FDA Breakthrough Device Designation

It assesses mortality risk in non-small cell lung cancer patients

Rowan DunneFebruary 11, 2025

FDA gives Zai Lab's small cell lung cancer therapeutic orphan drug designation

FDA gives Zai Lab's small cell lung cancer therapeutic orphan drug designation

Medical and Pharmaceutical

FDA gives Zai Lab’s small cell lung cancer therapeutic orphan drug designation

About 372,000 people are diagnosed with SCLC annually worldwide

Rowan DunneJanuary 27, 2025

Sagimet Biosciences up 30% on strong clinical stage data

Sagimet Biosciences up 30% on strong clinical stage data

Medical and Pharmaceutical

Sagimet Biosciences up 30% on strong clinical stage data

Denifanstat received FDA Breakthrough Therapy designation for metabolic dysfunction-associated steatohepatitis

Joseph MortonDecember 16, 2024

Neurogene patient dies in drug trial, stock surges after FDA says 'use lower dose'

Neurogene patient dies in drug trial, stock surges after FDA says 'use lower dose'

Medical and Pharmaceutical

Neurogene patient dies in drug trial, stock surges after FDA says ‘use lower dose’

This unfortunate incident occurred during a study on the company's Rett syndrome therapeutic NGN-401

Rowan DunneNovember 22, 2024

FDA gives long awaited green light to veterans cannabis trial for PTSD

FDA gives long awaited green light to veterans cannabis trial for PTSD

Cannabis

FDA gives long-awaited green light to veterans cannabis trial for PTSD

After 3 years of negotiating, a cannabis smoking study with 320 American vets is about to kick off

Rowan DunneNovember 20, 2024

Breath Diagnostics onboard new president and closes critical financing

Breath Diagnostics onboard new president and closes critical financing

Health & Wellness

Breath Diagnostics onboards new president and closes critical financing

Aaron Roebuck brings three decades of experience in respiratory and cardiopulmonary medicine, and commercialization of medical devices

Joseph MortonOctober 31, 2024

Mira Pharma up 27% on ketamine analog trial results for chemotherapy pain

Mira Pharma up 27% on ketamine analog trial results for chemotherapy pain

Medical and Pharmaceutical

MIRA Pharma up 27% on ketamine analogue’s preclinical results for chemotherapy pain

This pharmaceutical company is also developing a synthetic cannabinoid drug to treat anxiety and cognitive decline

Rowan DunneOctober 30, 2024

Switzerland's Novocure scoops FDA approval for electric lung cancer treatment device

Switzerland's Novocure scoops FDA approval for electric lung cancer treatment device

Medical and Pharmaceutical

Novocure scoops FDA approval for electric field lung cancer treatment device

The Swiss oncology company's stock rose by over 33% as a result

Rowan DunneOctober 16, 2024

Vivos Therapeutics surges on FDA approval for youth sleep apnea treatment device

Vivos Therapeutics surges on FDA approval for youth sleep apnea treatment device

Sleep

Vivos Therapeutics surges on FDA approval for youth sleep apnea treatment device

Over 10 million young people in the U.S. are impacted by the disorder

Rowan DunneSeptember 18, 2024

More Posts

Page 1 of 512 3 4 5